Recent LABS News
- MediPharm Labs Provides Conference Call Recording Details • PR Newswire (Canada) • 03/27/2024 02:54:00 PM
- MediPharm Labs Provides Conference Call Recording Details • PR Newswire (US) • 03/27/2024 02:54:00 PM
- MediPharm Labs Reports Fourth Quarter and Full Year Results • PR Newswire (Canada) • 03/27/2024 10:30:00 AM
- MediPharm Labs Reports Fourth Quarter and Full Year Results • PR Newswire (US) • 03/27/2024 10:30:00 AM
- MediPharm Labs Provides Update on German Cannabis Legalization • PR Newswire (US) • 03/25/2024 10:30:00 AM
- MediPharm Labs Provides Update on German Cannabis Legalization • PR Newswire (Canada) • 03/25/2024 10:30:00 AM
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results • PR Newswire (US) • 03/22/2024 10:30:00 AM
- MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results • PR Newswire (Canada) • 03/22/2024 10:30:00 AM
- MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority • PR Newswire (US) • 02/07/2024 11:30:00 AM
- MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority • PR Newswire (Canada) • 02/07/2024 11:30:00 AM
- MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program • PR Newswire (US) • 12/22/2023 12:00:00 PM
- MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program • PR Newswire (Canada) • 12/22/2023 12:00:00 PM
- MediPharm Labs Reports Third Quarter Results • PR Newswire (Canada) • 11/14/2023 12:15:00 PM
- MediPharm Labs Reports Third Quarter Results • PR Newswire (US) • 11/14/2023 12:15:00 PM
- MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results • PR Newswire (Canada) • 11/08/2023 10:01:00 PM
- MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results • PR Newswire (US) • 11/08/2023 10:01:00 PM
- MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash • PR Newswire (Canada) • 10/25/2023 11:00:00 AM
- MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash • PR Newswire (US) • 10/25/2023 11:00:00 AM
- MediPharm Labs Settles an Outstanding Claim for $9M • PR Newswire (Canada) • 10/02/2023 11:00:00 AM
- MediPharm Labs Settles an Outstanding Claim for $9M • PR Newswire (US) • 10/02/2023 11:00:00 AM
- MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market • PR Newswire (Canada) • 09/27/2023 11:15:00 AM
- MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market • PR Newswire (US) • 09/27/2023 11:15:00 AM
- MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement • PR Newswire (US) • 09/20/2023 11:00:00 AM
- MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement • PR Newswire (Canada) • 09/20/2023 11:00:00 AM
- MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million • PR Newswire (US) • 09/05/2023 11:39:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM